Can I Take Calcium with Jatenzo? Interaction Risk, Timing, and Monitoring

Can I Take Calcium with Jatenzo?
At a glance
- Direct interaction / No established pharmacokinetic conflict between calcium and Jatenzo
- Jatenzo absorption / Requires a fat-containing meal (at least 30 g dietary fat) for adequate uptake via intestinal lymphatics [1]
- Calcium form matters / Calcium citrate absorbs without food; calcium carbonate needs gastric acid and should be taken with meals [2]
- Dose-separation window / A 2-hour gap between calcium and Jatenzo removes any theoretical mineral-chelation concern
- Cardiovascular overlap / Jatenzo raised systolic blood pressure by 3 to 5 mmHg in its key trial, and calcium supplements above 1,000 mg/day have been linked to modest CV signal in some meta-analyses [3][4]
- Bone density context / Men on TRT for hypogonadism often have low baseline BMD; calcium plus vitamin D remains standard adjunct therapy [5]
- Monitoring / Check hematocrit, lipid panel, and blood pressure at baseline, 3 months, and every 6 to 12 months thereafter [6]
- Thyroid medication caution / If you also take levothyroxine, separate calcium from the thyroid drug by at least 4 hours [7]
Why This Question Comes Up
Men prescribed Jatenzo for hypogonadism frequently take calcium and vitamin D for bone health, joint support, or because a prior DEXA scan showed low bone mineral density. Hypogonadal men lose cortical bone at roughly 1 to 2% per year before testosterone replacement begins [5]. Adding calcium feels intuitive.
The Concern
The worry is rooted in how mineral supplements behave with other oral drugs. Calcium carbonate raises gastric pH and can chelate certain medications (fluoroquinolones, tetracyclines, levothyroxine, bisphosphonates), reducing their bioavailability by 20 to 40% depending on the drug [7]. Patients often generalize this to every oral medication, including Jatenzo.
Why Jatenzo Is Different
Jatenzo's absorption pathway is unusual. Oral testosterone undecanoate is a lipophilic prodrug that bypasses portal circulation by entering the intestinal lymphatic system when taken with dietary fat [1]. This lymphatic route is not governed by the same gastric pH or chelation dynamics that affect water-soluble drugs. No published interaction study in PubMed or the FDA label for Jatenzo lists calcium as a contraindicated or cautioned co-administration [8].
How Jatenzo Is Absorbed
Understanding lymphatic absorption explains why calcium is unlikely to interfere with Jatenzo pharmacokinetics.
The Lymphatic Pathway
Testosterone undecanoate dissolves into dietary lipids in the small intestine. Enterocytes package it into chylomicrons, which drain into mesenteric lymph nodes and then the thoracic duct before reaching systemic circulation [1]. This process depends on concurrent fat intake, not gastric acid levels.
Fat Requirement
The Jatenzo prescribing information specifies taking each dose with food. In the registrational study (SOAR, NCT03187015), subjects who consumed meals with at least 30 g of fat achieved mean steady-state testosterone concentrations (Cavg) of 489 ng/dL at the 237 mg twice-daily dose [8]. Under fasting conditions, AUC dropped by approximately 40%. This fat dependency is the rate-limiting factor for Jatenzo absorption. Calcium does not compete with this mechanism.
Gastric pH Considerations
Calcium carbonate is an antacid that transiently raises stomach pH. For drugs absorbed in the stomach or proximal duodenum via passive diffusion, this pH shift can matter. Jatenzo's active absorption occurs further downstream, in the jejunum and ileum, where lymphatic uptake dominates [1]. Calcium citrate does not meaningfully alter gastric pH and absorbs independently of acid, making it even less likely to interact.
The Cardiovascular Overlap You Should Know About
The more meaningful clinical conversation is not about absorption. It is about additive cardiovascular signals.
Jatenzo and Blood Pressure
In the SOAR trial (N=166), Jatenzo increased mean systolic blood pressure by 3.3 mmHg compared to baseline at 12 months, and 18.2% of subjects developed new-onset hypertension (systolic blood pressure of 140 mmHg or above) during treatment [3]. The FDA added a boxed warning for major adverse cardiovascular events (MACE) to all testosterone products in 2023, citing data from the TRAVERSE trial (N=5,246), which showed a hazard ratio of 0.96 (95% CI: 0.78 to 1.17) for testosterone gel versus placebo, a non-significant finding but one that did not rule out modest risk in longer follow-up [9].
Calcium and CV Risk
A 2010 BMJ meta-analysis by Bolland et al. (N=11,921 across 11 trials) reported that calcium supplements (without co-administered vitamin D) were associated with a 27% increase in myocardial infarction risk (HR 1.27, 95% CI: 1.01 to 1.59) [4]. A later re-analysis including the Women's Health Initiative data was less definitive, and the 2018 U.S. Preventive Services Task Force statement found insufficient evidence to assess the balance of benefits and harms of supplemental calcium above 1,000 mg/day for fracture prevention in community-dwelling adults [10].
Practical Takeaway
Neither signal is strong enough to contraindicate the combination, but the overlap means men on Jatenzo who also take calcium above 1,000 mg/day should have blood pressure and lipids checked more frequently than the standard TRT monitoring schedule alone would require.
HealthRX Dose-Separation and Monitoring Framework
This decision framework helps clinicians and patients determine whether dose separation is needed and what monitoring cadence to follow when combining calcium with Jatenzo.
Step 1: Identify the calcium formulation.
- Calcium citrate: no acid-dependent absorption, minimal chelation risk. Can be taken at the same meal as Jatenzo.
- Calcium carbonate: mild antacid effect, theoretical chelation. Separate by 2 hours from Jatenzo as a precaution.
Step 2: Confirm fat-containing meal timing.
- Jatenzo must be taken with a meal containing at least 30 g of fat. If calcium is taken at a different meal or snack, no timing conflict exists.
Step 3: Check for thyroid or bisphosphonate co-medications.
- If the patient also takes levothyroxine: separate calcium by 4 hours from the thyroid medication [7].
- If the patient also takes alendronate or risedronate: take the bisphosphonate on an empty stomach, 30 minutes before any food, calcium, or Jatenzo.
Step 4: Set monitoring cadence.
- Baseline: hematocrit, lipid panel, PSA, blood pressure, 25-hydroxyvitamin D, serum calcium.
- 3 months: repeat hematocrit, blood pressure, and testosterone trough level.
- Every 6 months thereafter: lipid panel, blood pressure, hematocrit.
- Annual: DEXA if baseline T-score was below -1.0.
Step 5: Reassess calcium dose.
- Total elemental calcium (diet plus supplement) should not exceed 1,200 mg/day for men over 50, per the National Osteoporosis Foundation and Endocrine Society guidelines [5][11].
- If dietary calcium intake already exceeds 800 mg/day (roughly 3 servings of dairy), supplementation may be unnecessary.
Calcium Form: Carbonate vs. Citrate for Men on TRT
Not all calcium supplements behave the same way in the GI tract. The distinction matters when you are timing doses around a lipophilic drug.
Calcium Carbonate
Contains 40% elemental calcium by weight, making it the most concentrated and least expensive option. Requires gastric acid for dissolution, so it should be taken with meals [2]. In patients on proton pump inhibitors (PPIs), calcium carbonate absorption drops by roughly 40% [12]. If you take Jatenzo with a fatty breakfast and calcium carbonate with that same meal, absorption of both agents proceeds through independent pathways, but a 2-hour separation eliminates any theoretical concern about transient pH buffering.
Calcium Citrate
Contains 21% elemental calcium, so you need more tablets to reach the same elemental dose. Absorbs equally well with or without food and does not depend on gastric acid [2]. For men on PPIs or H2 blockers alongside Jatenzo, calcium citrate is the better choice. It can be taken at any time of day without regard to Jatenzo dosing.
What About Calcium from Food?
Dietary calcium (dairy, fortified plant milks, leafy greens, sardines) is absorbed gradually and does not produce the bolus spike in serum calcium that supplements create. The Bolland meta-analysis linking calcium to CV events focused on supplemental calcium at 500 mg or more per dose, not dietary sources [4]. For men on TRT who can meet their calcium needs through food, this may be the lowest-risk approach.
Bone Health in Hypogonadal Men: Why Calcium Still Matters
Testosterone deficiency is an underappreciated cause of male osteoporosis. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy notes that testosterone replacement improves lumbar spine BMD by 3 to 8% over 12 to 36 months, with the greatest gains seen in men with the lowest baseline levels [6].
The Combination with Calcium and Vitamin D
TRT rebuilds bone by stimulating osteoblast activity and reducing bone resorption markers like C-telopeptide (CTX). Calcium provides the raw mineral substrate for new bone formation. Vitamin D enables intestinal calcium absorption. Without adequate calcium and vitamin D, the anabolic bone signal from testosterone has less substrate to work with.
The Institute of Medicine recommends 1,000 mg/day of calcium and 600 IU/day of vitamin D for men aged 19 to 70, rising to 1,200 mg/day of calcium and 800 IU/day of vitamin D for men over 70 [11]. Many endocrinologists target 25-hydroxyvitamin D levels of 30 to 50 ng/mL in hypogonadal men, which often requires 2,000 to 4,000 IU/day of vitamin D3 supplementation [6].
When to Get a DEXA Scan
The Endocrine Society recommends DEXA screening for men with hypogonadism who have additional risk factors: age over 50, low BMI, glucocorticoid use, prior fragility fracture, or family history of osteoporosis [5]. If the T-score is below -1.0 at the lumbar spine or femoral neck, calcium and vitamin D supplementation becomes a standard co-intervention alongside TRT.
Who Should Avoid This Combination
There are a few clinical scenarios where calcium supplementation alongside Jatenzo requires closer scrutiny or may be inappropriate.
Hypercalcemia
Testosterone can increase serum calcium, particularly in immobilized patients or those with bone metastases. The Jatenzo label lists hypercalcemia as a known adverse reaction [8]. If baseline serum calcium is above 10.5 mg/dL, adding supplemental calcium is not appropriate until the cause is identified. Recheck ionized calcium and parathyroid hormone (PTH) before starting supplementation.
Advanced Kidney Disease
Men with eGFR below 30 mL/min/1.73m² accumulate calcium and are at risk for vascular calcification. Phosphate binders (calcium-based or otherwise) are managed by nephrology in this population. Do not add over-the-counter calcium without renal team clearance.
Concurrent High-Dose Vitamin D
Vitamin D at doses above 4,000 IU/day increases intestinal calcium absorption. Combined with supplemental calcium, this can push serum calcium above normal range. Monitor 25-hydroxyvitamin D and serum calcium together if the patient is on both.
Timing Recommendations in Practice
For most men, the simplest approach is this:
Take Jatenzo twice daily with fat-containing meals (breakfast and dinner). Take calcium citrate at lunch or bedtime, away from Jatenzo by default. If using calcium carbonate, take it with lunch rather than with the same fat-heavy meal as Jatenzo.
This schedule avoids any theoretical GI interaction, spaces calcium dosing for better fractional absorption (the body absorbs calcium more efficiently in doses of 500 mg or less), and keeps thyroid or bisphosphonate medications in their own timing windows if applicable.
A 2014 review in Therapeutic Advances in Drug Safety confirmed that splitting calcium into two or more daily doses of 500 mg improved absorption efficiency by 20 to 30% compared to single large doses [13]. This split-dosing strategy pairs naturally with twice-daily Jatenzo.
What to Tell Your Prescriber
If you are starting Jatenzo and already take calcium, bring your supplement bottle to your next visit. Your prescriber needs to know the calcium form (carbonate or citrate), elemental dose, and whether you co-administer vitamin D. They should also know about any other medications that interact with calcium, particularly levothyroxine, bisphosphonates, or fluoroquinolone antibiotics.
Ask for baseline labs: serum calcium, 25-hydroxyvitamin D, hematocrit, lipid panel, and blood pressure. These values establish the safety reference range for ongoing monitoring. At 3 months, a follow-up hematocrit and blood pressure check confirms that neither Jatenzo nor the supplement regimen is producing unexpected shifts.
Men on Jatenzo whose dietary calcium intake already exceeds 1,000 mg/day through food may not need supplementation at all. A registered dietitian can estimate dietary calcium intake from a 3-day food diary in roughly 10 minutes.
Frequently asked questions
›Can I take calcium while on Jatenzo?
›Does calcium interact with Jatenzo?
›What form of calcium is best while taking Jatenzo?
›Can Jatenzo cause high calcium levels?
›How much calcium should I take daily while on TRT?
›Should I take vitamin D with calcium while on Jatenzo?
›Do I need to fast before taking Jatenzo?
›Can calcium affect my testosterone blood levels on Jatenzo?
›Is it safe to take calcium and Jatenzo together long term?
›What labs should I get if I take calcium with Jatenzo?
›Does calcium carbonate reduce Jatenzo absorption?
›Can I take Tums with Jatenzo?
References
- Shackleford DM, Faassen WA, Humberstone AJ, et al. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. J Pharmacol Exp Ther. 2003;306(3):925-933. https://pubmed.ncbi.nlm.nih.gov/12766258/
- Heaney RP, Dowell MS, Bierman J, Hale CA, Bendich A. Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr. 2001;20(3):239-246. https://pubmed.ncbi.nlm.nih.gov/11444420/
- Swerdloff RS, Wang C, White WB, et al. A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. J Clin Endocrinol Metab. 2020;105(8):2515-2531. https://pubmed.ncbi.nlm.nih.gov/32382745/
- Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. https://pubmed.ncbi.nlm.nih.gov/20671013/
- Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(6):1802-1822. https://pubmed.ncbi.nlm.nih.gov/22675062/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-792. https://pubmed.ncbi.nlm.nih.gov/19942153/
- U.S. Food and Drug Administration. Jatenzo (testosterone undecanoate) prescribing information. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206089s000lbl.pdf
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37326322/
- U.S. Preventive Services Task Force. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults. JAMA. 2018;319(15):1592-1599. https://pubmed.ncbi.nlm.nih.gov/29677309/
- Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2011. https://pubmed.ncbi.nlm.nih.gov/21796828/
- O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118(7):778-781. https://pubmed.ncbi.nlm.nih.gov/15989913/
- Straub DA. Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutr Clin Pract. 2007;22(3):286-296. https://pubmed.ncbi.nlm.nih.gov/17507729/